Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Lingua: | |
| Pubblicazione: |
Zenodo
2025
|
| Accesso online: | https://doi.org/10.5281/zenodo.17955243 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901524117979136 |
|---|---|
| author | ULAGANADAN UMESHNATH |
| author_facet | ULAGANADAN UMESHNATH |
| contents | <p>Background: Meningococcal disease, caused by Neisseria meningitidis, remains a serious global health threat due to its rapid onset and high mortality. While effective conjugate vaccines exist, vaccination policies vary significantly worldwide based on disease epidemiology and resource allocation.</p> <p>Objective: This study aims to conduct a comparative analysis of global vaccination guidelines (WHO, CDC) versus the current national immunization policies of India regarding meningococcal disease.</p> <p>Methods: A descriptive review was conducted analyzing official policy documents from the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and India’s Ministry of Health and Family Welfare (MoHFW) published between 2015 and 2023.</p> <p>Results: Global guidelines recommend routine immunization of adolescents and high-risk groups with quadrivalent meningococcal conjugate vaccines (MenACWY). In contrast, India’s national policy does not include meningococcal vaccination in the Universal Immunization Programme (UIP). In India, vaccination is reactive (outbreak-based) or targeted at specific travelers (Hajj pilgrims), with limited proactive use in the general population.</p> <p>Conclusion: A significant disparity exists between proactive global standards and India’s reactive national strategy. While currently justified by epidemiological data, this gap suggests a need for continuous surveillance to determine if routine vaccination should be introduced</p> <p> </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_17955243 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Vaccination Strategies for Meningococcal Disease in India: Global Guidelines vs National Policies ULAGANADAN UMESHNATH <p>Background: Meningococcal disease, caused by Neisseria meningitidis, remains a serious global health threat due to its rapid onset and high mortality. While effective conjugate vaccines exist, vaccination policies vary significantly worldwide based on disease epidemiology and resource allocation.</p> <p>Objective: This study aims to conduct a comparative analysis of global vaccination guidelines (WHO, CDC) versus the current national immunization policies of India regarding meningococcal disease.</p> <p>Methods: A descriptive review was conducted analyzing official policy documents from the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and India’s Ministry of Health and Family Welfare (MoHFW) published between 2015 and 2023.</p> <p>Results: Global guidelines recommend routine immunization of adolescents and high-risk groups with quadrivalent meningococcal conjugate vaccines (MenACWY). In contrast, India’s national policy does not include meningococcal vaccination in the Universal Immunization Programme (UIP). In India, vaccination is reactive (outbreak-based) or targeted at specific travelers (Hajj pilgrims), with limited proactive use in the general population.</p> <p>Conclusion: A significant disparity exists between proactive global standards and India’s reactive national strategy. While currently justified by epidemiological data, this gap suggests a need for continuous surveillance to determine if routine vaccination should be introduced</p> <p> </p> |
| title | Vaccination Strategies for Meningococcal Disease in India: Global Guidelines vs National Policies |
| url | https://doi.org/10.5281/zenodo.17955243 |